日本語
 
Help Privacy Policy ポリシー/免責事項
  詳細検索ブラウズ

アイテム詳細


公開

学術論文

STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancer

MPS-Authors
/persons/resource/persons208862

Pecoraro,  Matteo
Mann, Matthias / Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Max Planck Society;

/persons/resource/persons78356

Mann,  Matthias
Mann, Matthias / Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Max Planck Society;

External Resource
There are no locators available
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
フルテキスト (公開)

MSB-16-e9247.pdf
(全文テキスト(全般)), 5MB

付随資料 (公開)
There is no public supplementary material available
引用

Oberhuber, M., Pecoraro, M., Rusz, M., Oberhuber, G., Wieselberg, M., Haslinger, P., Gurnhofer, E., Schlederer, M., Limberger, T., Lagger, S., Pencik, J., Kodajova, P., Högler, S., Stockmaier, G., Grund-Gröschke, S., Aberger, F., Bolis, M., Theurillat, J.-P., Wiebringhaus, R., Weiss, T., Haitel, A., Brehme, M., Wadsak, W., Griss, J., Mohr, T., Hofer, A., Jäger, A., Pollheimer, J., Egger, G., Koellensperger, G., Mann, M., Hantusch, B., & Kenner, L. (2020). STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancer. MOLECULAR SYSTEMS BIOLOGY, 16(4):. doi:10.15252/msb.20199247.


引用: https://hdl.handle.net/21.11116/0000-0006-72F2-8
要旨
Prostate cancer (PCa) has a broad spectrum of clinical behavior; hence, biomarkers are urgently needed for risk stratification. Here, we aim to find potential biomarkers for risk stratification, by utilizing a gene co-expression network of transcriptomics data in addition to laser-microdissected proteomics from human and murine prostate FFPE samples. We show up-regulation of oxidative phosphorylation (OXPHOS) in PCa on the transcriptomic level and up-regulation of the TCA cycle/OXPHOS on the proteomic level, which is inversely correlated to STAT3 expression. We hereby identify gene expression of pyruvate dehydrogenase kinase 4 (PDK4), a key regulator of the TCA cycle, as a promising independent prognostic marker in PCa. PDK4 predicts disease recurrence independent of diagnostic risk factors such as grading, staging, and PSA level. Therefore, low PDK4 is a promising marker for PCa with dismal prognosis.